Form 4: Orgenesis Inc. CEO Vered Caplan Acquires 85,000 Stock Options
SEC Form 4 Filing
Orgenesis Inc.'s CEO and Chairman of the Board, Vered Caplan, acquired 85,000 stock options on July 23, 2024, with vesting starting September 30, 2024.
Summary
- Vered Caplan, CEO and Chairman of the Board of Orgenesis Inc., acquired 85,000 stock options on July 23, 2024.
- The exercise price of these options is $0.64.
- The options vest equally over the next eight quarters, with the first vesting of 10,625 options commencing on September 30, 2024.
- The vesting is contingent upon Vered Caplan's continued service with the company through the applicable vesting dates.
- The options expire on July 22, 2034.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and suggests confidence in the company's future, but it doesn't provide concrete financial results.
Positives
- The CEO's acquisition of stock options may signal confidence in the company's future performance.
- The vesting schedule incentivizes continued service and commitment from the CEO.
Future Outlook
The vesting schedule suggests an expectation of continued service from the CEO over the next two years.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive sign, aligning the CEO's interests with theirs.
- Employees may see this as a sign of stability and commitment from the leadership.
Key Dates
| Date | Description |
|---|---|
| 07/23/2024 | Date of transaction: Vered Caplan acquired 85,000 stock options. |
| 09/30/2024 | First vesting date: 10,625 options commence vesting. |
| 07/22/2034 | Expiration date of the stock options. |
| 07/25/2024 | Date of signature on the Form 4. |
Keywords
stock options, Orgenesis Inc., Vered Caplan, CEO, Form 4, beneficial ownership, equity securities, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.